erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
submit a letter to the editor
.
.
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.
.
.
.
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.
.
.